Neue Suche | Kongressdetail
Druckansicht
 
 

Allogeneic Cell Therapies Summit 2021

Evvnt Promotion / evvnt
-
17.05.2021 - 19.05.2021  Online
Time: 09:00 - 17:00
 
Kongressthemen
Patient-specific cell therapies have changed the face of cancer treatment, but with price points sky high and laborious manufacturing processes, this cure is out of reach for many patients.

The 3rd annual Allogeneic Cell Therapies Summit is the only industry-focused meeting dedicated to accelerating the clinical translation of allogeneic cell therapy, to provide an affordable and accessible treatment for patients globally.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Sonny Hsiao, Founder and CEO, Acepodia, Nathan Yee, Associate Director, CMC Product Strategy, Allogeneic Cell Therapy, Bristol Myers Squibb, Joanna Brewer, SVP, Allogeneic Research, Adaptimmune and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/737980-1?pid=4832
Herr Allogeneic Cell Therapies Team
 
Kategorien
Onkologie
Sprache
Englisch
Kongressgebühr
Drug Developers (Earlybird rates and bootcamp day available): USD 2299.0, Academic (Earlybird rates and bootcamp day available): USD 1799.0, Service Providers (Earlybird rates and bootcamp day available): USD 2699.0
Teilnehmer erwartet
250
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

European Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Helix - Forschung & Beratung WienAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaÖsterreichische Akademie der ÄrztenewTreeAGEM - Arbeitsgemeinschaft Ethnologie und Medizin